Published in J Med Virol on March 01, 1995
The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol (1999) 1.76
Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen. J Virol (1999) 1.39
Recovery efficiences on nucleic acid extraction kits as measured by quantitative LightCycler PCR. Mol Pathol (2001) 1.36
Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus. J Virol (2002) 1.06
Low frequency of mutations in the core promoter and precore regions of hepatitis B virus in anti-HBe positive Brazilian carriers. BMC Microbiol (2001) 0.97
Current Scenario of Hepatitis B and Its Treatment in India. J Clin Transl Hepatol (2017) 0.75
Vaccine-induced escape mutant of hepatitis B virus. Lancet (1990) 5.31
Who should be immunised against hepatitis B? Br Med J (Clin Res Ed) (1984) 4.30
Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J (1970) 4.08
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
Tissue culture of human embryo liver cells and the cytotoxicity of aflatoxin B1. Br J Exp Pathol (1967) 2.62
Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis (2002) 2.39
A three-year survey of viral hepatitis in West London. Q J Med (1978) 2.37
Persistence of the serum hepatitis (SH-Australia) antigen for many years. Nature (1969) 2.37
ABO Blood Groups and Acute Respiratory Virus Disease. Br Med J (1962) 2.30
Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet (1973) 2.17
Community prevalence of sexually transmitted diseases and human immunodeficiency virus infection in Tamil Nadu, India: a probability proportional to size cluster survey. Natl Med J India (2002) 2.01
Hepatitis B virus infection in two Gambian villages. Lancet (1983) 1.92
The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. J Gen Virol (2000) 1.89
EDRF coordinates the behaviour of vascular resistance vessels. Nature (1987) 1.86
HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature (1988) 1.84
Hepatitis-B antibody in polymyalgia Rheumatica. Lancet (1975) 1.77
Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine (1995) 1.71
Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr (2002) 1.71
Exposure and immunity to hepatitis-B virus in a liver unit. Lancet (1974) 1.68
Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet (1975) 1.65
Genital syndromes and syndromic management of vaginal discharge in a community setting. Int J STD AIDS (2004) 1.64
The complete nucleotide sequence of the genome of a hepatitis B virus isolated from a naturally infected chimpanzee. J Gen Virol (1988) 1.62
A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol (1999) 1.59
Further trials of live influenza vaccine. Br Med J (1966) 1.58
Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol (2005) 1.57
Non-A, non-B hepatitis in West London. Lancet (1981) 1.52
Viral hepatitis and the Australia-SH antigen. Nature (1969) 1.50
Phyllanthus amarus and hepatitis B. Lancet (1990) 1.49
Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J Med Virol (1985) 1.48
Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis. Br Med J (1975) 1.47
Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet (1984) 1.47
Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol (1994) 1.43
Australia antigen as a marker of propagation of the serum hepatitis virus in liver cultures. Nature (1972) 1.43
Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods. Gut (1976) 1.42
Specific serological diagnosis of viral hepatitis. Br Med J (1979) 1.42
The labelling of galactose residues in hepatitis B surface antigen glycoprotein. J Gen Virol (1978) 1.40
Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J Med Virol (1977) 1.39
Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantation. J Med Virol (1987) 1.39
Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B. J Med Virol (1989) 1.34
Recovery of human foetal liver cells after storage in liquid nitrogen. J Clin Pathol (1968) 1.34
The Australia (hepatitis-associated) antigen amongst heroin addicts attending a London addiction clinic. J Hyg (Lond) (1971) 1.31
Hepatitis B variant in Europe. Lancet (1988) 1.31
Dried blood spots (DBS): a valuable tool for HIV surveillance in developing/tropical countries. Int J STD AIDS (2002) 1.29
Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B. Br Med J (1976) 1.28
Perinatal transmission of hepatitis B. Arch Dis Child (1984) 1.28
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
High proportion of isosporiasis among HIV-infected patients with diarrhea in southern India. Am J Trop Med Hyg (2007) 1.26
The three type of human viral hepatitis. Bull World Health Organ (1978) 1.26
Role of mosquitoes in transmission of hepatitis B antigen. J Infect Dis (1973) 1.24
Priorities for immunisation against hepatitis B. Br Med J (Clin Res Ed) (1982) 1.24
Effect of ethanol during hepatitis B virus infection in chimpanzees. J Med Virol (1978) 1.24
Current topics in hepatitis B. J Infect (2000) 1.23
Evidence for the presence of hepatitis E virus in pigs in the United Kingdom. Vet Rec (2004) 1.23
Appraisal of intradermal immunisation against hepatitis B. Lancet (1987) 1.23
Letter: Virus-like particles in hepatitis-A-positive faecal extracts. Lancet (1974) 1.21
Hepatitis B surface antigen produced by a human hepatoma cell line. Nature (1979) 1.21
Screening for transmission of hepatitis within a liver unit. J Hyg (Lond) (1972) 1.21
Hepatitis A antibody in blood donors in North East Thames region: implications to prevention policies. Epidemiol Infect (1989) 1.20
Tests for the hepatitis-associated antigen. Brief report. Arch Gesamte Virusforsch (1970) 1.20
Analysis of hepatitis B surface antigen components solubilized with Triton X-100. J Gen Virol (1979) 1.19
The mechanism of replication of hepatitis B virus: evidence of asymmetric replication of the two DNA strands. J Med Virol (1984) 1.18
Presence of particles other than the Australia-SH antigen in a case of chronic active hepatitis with cirrhosis. Br Med J (1970) 1.18
Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res (2005) 1.16
Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol (1995) 1.16
Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol (1987) 1.16
HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China. J Med Virol (1998) 1.14
AIDS in primates. Br Med J (Clin Res Ed) (1986) 1.13
Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4. J Clin Microbiol (2001) 1.13
Hepatitis B polypeptide vaccine preparation in micelle form. Nature (1981) 1.12
Australia-SH antigen in hepatitis patients in London. Br Med J (1969) 1.12
More than third of world's population has been infected with hepatitis B virus. BMJ (1999) 1.12
The growth of the caudal half of the pelvis in the rat. J Anat (1968) 1.10
Viral hepatitis: report on WHO informal consultation. J Med Virol (1981) 1.10
Review: antigens and viruses in acute hepatitis. Clin Exp Immunol (1970) 1.09
Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol (1991) 1.09
The effect of heliotrine, a pyrrolizidine alkaloid, on human liver cells in culture. Br J Exp Pathol (1969) 1.09
Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus. J Clin Microbiol (1999) 1.08
Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis. Gut (1977) 1.08
Taxonomic classification of human hepatitis B virus. Intervirology (1986) 1.07
Palaeontology of smallpox. Lancet (1984) 1.06
Endothelium-derived relaxing factor (EDRF) and resistance vessels in an intact vascular bed: a microangiographic study of the rabbit isolated ear. Br J Pharmacol (1988) 1.06
Syringe-transmitted hepatitis. Br Med J (1978) 1.06
Antimicrobial effect of fermented Ghanaian maize dough. J Appl Bacteriol (1991) 1.05
Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. Eur J Clin Invest (1997) 1.05
Characterization of hepatitis B antigen polypeptides. Intervirology (1974) 1.05
Changes induced by hepatitis serum in cultured liver cells. Nat New Biol (1971) 1.04
Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol (2001) 1.04
Infection of human liver cell cultures with the San Carlos viruses. Br J Exp Pathol (1968) 1.03
New human hepatitis virus. Lancet (1979) 1.03
Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis. Lancet (1973) 1.02
Non-A/non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies. J Med Virol (1980) 1.02
Enterically transmitted non-A, non-B hepatitis: recovery of virus-like particles from an epidemic in south Delhi and transmission studies in rhesus monkeys. Hepatology (1989) 1.02
Further evidence of cellular changes associated with non-A, non-B hepatitis. J Med Virol (1980) 1.02
Evaluation of immunogenicity and safety of Genevac B: a new recombinant hepatitis B vaccine in comparison with Engerix B and Shanvac B in healthy adults. Indian J Med Microbiol (2007) 1.02
Incidence of burn wound sepsis in 600 burned patients treated in a developing country. Burns Incl Therm Inj (1985) 1.01